Annual Cash & Cash Equivalents
$37.19 M
-$114.38 M-75.47%
31 December 2021
Summary:
Aerie Pharmaceuticals annual cash & cash equivalents is currently $37.19 million, with the most recent change of -$114.38 million (-75.47%) on 31 December 2021. During the last 3 years, it has fallen by -$114.38 million (-75.47%).AERI Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$54.09 M
+$14.65 M+37.15%
30 September 2022
Summary:
Aerie Pharmaceuticals quarterly cash and cash equivalents is currently $54.09 million, with the most recent change of +$14.65 million (+37.15%) on 30 September 2022.AERI Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AERI Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | -75.5% | -12.5% |
| 5 y5 years | -81.7% | -78.3% |
AERI Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -81.7% | -80.0% |
Aerie Pharmaceuticals Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $54.09 M(+37.1%) |
| June 2022 | - | $39.44 M(-30.1%) |
| Mar 2022 | - | $56.44 M(+51.8%) |
| Dec 2021 | $37.19 M(-75.5%) | $37.19 M(-39.9%) |
| Sept 2021 | - | $61.85 M(-22.6%) |
| June 2021 | - | $79.96 M(-34.8%) |
| Mar 2021 | - | $122.69 M(-19.1%) |
| Dec 2020 | $151.57 M(+5.3%) | $151.57 M(+16.8%) |
| Sept 2020 | - | $129.79 M(-14.2%) |
| June 2020 | - | $151.30 M(+12.8%) |
| Mar 2020 | - | $134.18 M(-6.8%) |
| Dec 2019 | $143.94 M(-29.0%) | $143.94 M(-42.1%) |
| Sept 2019 | - | $248.70 M(+127.4%) |
| June 2019 | - | $109.36 M(-26.5%) |
| Mar 2019 | - | $148.87 M(-26.6%) |
| Dec 2018 | $202.82 M(+2.7%) | $202.82 M(-13.7%) |
| Sept 2018 | - | $234.95 M(-13.2%) |
| June 2018 | - | $270.65 M(+8.5%) |
| Mar 2018 | - | $249.50 M(+26.3%) |
| Dec 2017 | $197.57 M | $197.57 M(+1.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2017 | - | $194.08 M(-20.0%) |
| June 2017 | - | $242.65 M(+73.9%) |
| Mar 2017 | - | $139.53 M(-29.5%) |
| Dec 2016 | $197.94 M(+117.4%) | $197.94 M(-6.6%) |
| Sept 2016 | - | $211.94 M(+262.2%) |
| June 2016 | - | $58.52 M(-21.2%) |
| Mar 2016 | - | $74.27 M(-18.4%) |
| Dec 2015 | $91.06 M(+6.4%) | $91.06 M(-14.9%) |
| Sept 2015 | - | $106.95 M(+6.0%) |
| June 2015 | - | $100.92 M(-11.0%) |
| Mar 2015 | - | $113.45 M(+32.6%) |
| Dec 2014 | $85.59 M(+22.9%) | $85.59 M(-42.5%) |
| Sept 2014 | - | $148.88 M(+434.1%) |
| June 2014 | - | $27.88 M(-22.2%) |
| Mar 2014 | - | $35.84 M(-48.5%) |
| Dec 2013 | $69.65 M(+2281.2%) | $69.65 M(+1407.9%) |
| Sept 2013 | - | $4.62 M(+94.3%) |
| June 2013 | - | $2.38 M(-18.7%) |
| Dec 2012 | $2.92 M(-80.6%) | $2.92 M |
| Dec 2011 | $15.07 M | - |
FAQ
- What is Aerie Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Aerie Pharmaceuticals?
- What is Aerie Pharmaceuticals quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Aerie Pharmaceuticals?
What is Aerie Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of AERI is $37.19 M
What is the all time high annual cash & cash equivalents for Aerie Pharmaceuticals?
Aerie Pharmaceuticals all-time high annual cash & cash equivalents is $202.82 M
What is Aerie Pharmaceuticals quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of AERI is $54.09 M
What is the all time high quarterly cash and cash equivalents for Aerie Pharmaceuticals?
Aerie Pharmaceuticals all-time high quarterly cash and cash equivalents is $270.65 M